Whereas an s.c. injection will program elicited T cells to home towards the skin, i.v. injection of DCs induces splenic CD8+ T cells capable of homing towards hematogenic metastases, which is especially relevant for lung cancer. The gene discussed is CD8A; the disease is lung carcinoma.